BioNTech SE’s founders will leave the company to start a new biotech focused on messenger RNA, the technology behind their ...
BioNTech SE’s founders will leave the company to start a new biotech focused on messenger RNA, the technology behind their blockbuster Covid-19 vaccine, dashing investors’ confidence in the firm’s ...
Right before BioNTech was due to announce its 2025 results, the company’s co‑founders, Ugur Sahin and Özlem Türeci, revealed they would leave the company to focus on develop ...
A cleantech growth story for around CAD 35 million Is CHAR Technologies’ stock finally ready to take off? The Canadians are ...
Advisers to RFK Jr drop the plan to end federal guidance amid Republican worries about the political impact ...
From billion-dollar licensing deals to advances in cancer therapies and artificial intelligence, Chinese biotech firms are reshaping the global drug industry.
BioNTech's cofounders Ugur Sahin and Oezlem Tuereci will depart the company by 2026 to establish a new venture focusing on ...
BioNTech's co-founders, Ugur Sahin and Oezlem Tuereci, plan to leave by year's end to start a new venture, causing BioNTech's shares to plummet. The couple aims to focus on mRNA-based drugs at an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results